Cargando…

Extracellular matrix alterations in the Peyronie’s disease()

Peyronie’s disease is characterized by fibrous plaque formation of the tunica albuginea, causing penile deformity and fertility problems. The aim of the present study was to investigate alterations in the extracellular matrix in Peyronie’s disease. The study used tissues collected by surgical proced...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Marcelo Silva, Theodoro, Thérèse Rachel, Coelho, Natália Lima, Mendes, Aline, Leonel, Monica Luzia Pereira, Mader, Ana Maria, Nader, Helena Bonciani, Glina, Sidney, Pinhal, Maria Aparecida Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491452/
https://www.ncbi.nlm.nih.gov/pubmed/28721300
http://dx.doi.org/10.1016/j.jare.2017.06.004
_version_ 1783247129079185408
author Watanabe, Marcelo Silva
Theodoro, Thérèse Rachel
Coelho, Natália Lima
Mendes, Aline
Leonel, Monica Luzia Pereira
Mader, Ana Maria
Nader, Helena Bonciani
Glina, Sidney
Pinhal, Maria Aparecida Silva
author_facet Watanabe, Marcelo Silva
Theodoro, Thérèse Rachel
Coelho, Natália Lima
Mendes, Aline
Leonel, Monica Luzia Pereira
Mader, Ana Maria
Nader, Helena Bonciani
Glina, Sidney
Pinhal, Maria Aparecida Silva
author_sort Watanabe, Marcelo Silva
collection PubMed
description Peyronie’s disease is characterized by fibrous plaque formation of the tunica albuginea, causing penile deformity and fertility problems. The aim of the present study was to investigate alterations in the extracellular matrix in Peyronie’s disease. The study used tissues collected by surgical procedure from individuals that presented a well-established disease, while control samples were obtained by biopsies of fresh cadavers. Immunohistochemistry analysis followed by digital quantification was performed to evaluate TGF-β, heparanases and metalloproteinases (MMPs). The profile of sulfated glycosaminoglycans, chondroitin sulfate and dermatan sulfate was determined by agarose gel electrophoresis, while hyaluronic acid quantification was obtained by an ELISA-like assay. The expression of mRNA was investigated for syndecan-1 proteoglycan (Syn-1), interleukine-6 (IL-6), hyaluronic acid synthases, and hyaluronidases. Pathologic features showed decreased apoptosis and blood vessel number in Peyronie’s tissues. TGF-β and IL-6 were significantly enhanced in Peyronie’s disease. There was an increased expression of heparanases, though no alteration was observed for MMPs. Hyaluronic acid as well as hyaluronic acid synthases, hyaluronidases, and dermatan sulfate were not changed, while the level of chondroitin sulfate was significantly (P = 0.008, Mann-Whitney test) increased in Peyronie’s samples. Heparanases and sulfated glycosaminoglycans seem to be involved in extracellular matrix alterations in Peyronie’s disease.
format Online
Article
Text
id pubmed-5491452
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54914522017-07-18 Extracellular matrix alterations in the Peyronie’s disease() Watanabe, Marcelo Silva Theodoro, Thérèse Rachel Coelho, Natália Lima Mendes, Aline Leonel, Monica Luzia Pereira Mader, Ana Maria Nader, Helena Bonciani Glina, Sidney Pinhal, Maria Aparecida Silva J Adv Res Original Article Peyronie’s disease is characterized by fibrous plaque formation of the tunica albuginea, causing penile deformity and fertility problems. The aim of the present study was to investigate alterations in the extracellular matrix in Peyronie’s disease. The study used tissues collected by surgical procedure from individuals that presented a well-established disease, while control samples were obtained by biopsies of fresh cadavers. Immunohistochemistry analysis followed by digital quantification was performed to evaluate TGF-β, heparanases and metalloproteinases (MMPs). The profile of sulfated glycosaminoglycans, chondroitin sulfate and dermatan sulfate was determined by agarose gel electrophoresis, while hyaluronic acid quantification was obtained by an ELISA-like assay. The expression of mRNA was investigated for syndecan-1 proteoglycan (Syn-1), interleukine-6 (IL-6), hyaluronic acid synthases, and hyaluronidases. Pathologic features showed decreased apoptosis and blood vessel number in Peyronie’s tissues. TGF-β and IL-6 were significantly enhanced in Peyronie’s disease. There was an increased expression of heparanases, though no alteration was observed for MMPs. Hyaluronic acid as well as hyaluronic acid synthases, hyaluronidases, and dermatan sulfate were not changed, while the level of chondroitin sulfate was significantly (P = 0.008, Mann-Whitney test) increased in Peyronie’s samples. Heparanases and sulfated glycosaminoglycans seem to be involved in extracellular matrix alterations in Peyronie’s disease. Elsevier 2017-07 2017-06-15 /pmc/articles/PMC5491452/ /pubmed/28721300 http://dx.doi.org/10.1016/j.jare.2017.06.004 Text en © 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Watanabe, Marcelo Silva
Theodoro, Thérèse Rachel
Coelho, Natália Lima
Mendes, Aline
Leonel, Monica Luzia Pereira
Mader, Ana Maria
Nader, Helena Bonciani
Glina, Sidney
Pinhal, Maria Aparecida Silva
Extracellular matrix alterations in the Peyronie’s disease()
title Extracellular matrix alterations in the Peyronie’s disease()
title_full Extracellular matrix alterations in the Peyronie’s disease()
title_fullStr Extracellular matrix alterations in the Peyronie’s disease()
title_full_unstemmed Extracellular matrix alterations in the Peyronie’s disease()
title_short Extracellular matrix alterations in the Peyronie’s disease()
title_sort extracellular matrix alterations in the peyronie’s disease()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491452/
https://www.ncbi.nlm.nih.gov/pubmed/28721300
http://dx.doi.org/10.1016/j.jare.2017.06.004
work_keys_str_mv AT watanabemarcelosilva extracellularmatrixalterationsinthepeyroniesdisease
AT theodorothereserachel extracellularmatrixalterationsinthepeyroniesdisease
AT coelhonatalialima extracellularmatrixalterationsinthepeyroniesdisease
AT mendesaline extracellularmatrixalterationsinthepeyroniesdisease
AT leonelmonicaluziapereira extracellularmatrixalterationsinthepeyroniesdisease
AT maderanamaria extracellularmatrixalterationsinthepeyroniesdisease
AT naderhelenabonciani extracellularmatrixalterationsinthepeyroniesdisease
AT glinasidney extracellularmatrixalterationsinthepeyroniesdisease
AT pinhalmariaaparecidasilva extracellularmatrixalterationsinthepeyroniesdisease